Cargando…
Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis
PURPOSE: To compare the impact of postoperative chemoradiotherapy (CRT) versus adjuvant chemotherapy alone on recurrence and survival in patients with stage II and III upper rectal cancer undergoing curative resection. MATERIALS AND METHODS: From our institutional database, 190 patients who underwen...
Autores principales: | Song, Changhoon, Song, Sanghyuk, Kim, Jae-Sung, Oh, Heung-Kwon, Kim, Duck-Woo, Lee, Keun-Wook, Kim, Jee Hyun, Eom, Keun-Yong, Kim, In Ah, Kang, Sung-Bum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406553/ https://www.ncbi.nlm.nih.gov/pubmed/25902069 http://dx.doi.org/10.1371/journal.pone.0123657 |
Ejemplares similares
-
Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
por: Song, Changhoon, et al.
Publicado: (2018) -
p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer
por: Sim, Sung Hoon, et al.
Publicado: (2014) -
Lymph node ratio determines the benefit of adjuvant radiotherapy in pathologically 3 or less lymph node-positive prostate cancer after radical prostatectomy: a population-based analysis with propensity-score matching
por: Kim, Yi-Jun, et al.
Publicado: (2017) -
Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015) -
GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer
por: Kim, Tae Hyun, et al.
Publicado: (2023)